Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors

Nature Medicine
I MeleroL Chen

Abstract

The 4-1BB glycoprotein is a member of the tumor necrosis factor receptor superfamily and binds to a high-affinity ligand (4-1BBL) expressed on several antigen-presenting cells such as macrophages and activated B cells. Expression of 4-1BB is restricted to primed CD4+ and CD8+ T cells, and 4-1BB signaling either by binding to 4-1BBL or by antibody ligation delivers a dual mitogenic signal for T-cell activation and growth. These observations suggest an important role for 4-1BB in the amplification of T cell-mediated immune responses. We now show that administration of anti-4-1BB monoclonal antibodies can eradicate established large tumors in mice, including the poorly immunogenic Ag104A sarcoma and the highly tumorigenic P815 masto cytoma. The immune response induced by anti-4- 1BB monoclonal antibodies is mediated by both CD8+ and CD4+ T cells and is accompanied by a marked augmentation of tumor-selective cytolytic T-cell activity. Our data suggest that a similar approach may be efficacious for immunotherapy of human cancer.

References

Mar 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·B S Kwon, S M Weissman
Feb 1, 1994·The Journal of Experimental Medicine·L ChenK E Hellström
Mar 1, 1995·The Journal of Experimental Medicine·M A DeBenedetteT H Watts
Aug 1, 1994·Immunity·T L WalunasJ A Bluestone
Jan 1, 1994·Annual Review of Immunology·R A Seder, W E Paul
Jun 1, 1994·Current Opinion in Immunology·R J Armitage
Sep 1, 1994·European Journal of Immunology·M R AldersonW S Din
Mar 22, 1996·Science·D R LeachJ P Allison
Feb 1, 1996·The Journal of Experimental Medicine·Y LiL Chen

❮ Previous
Next ❯

Citations

Apr 29, 1998·European Journal of Immunology·Y J KimB S Kwon
Dec 25, 2010·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Jun-Sang BaeHyeon-Woo Lee
Aug 23, 2006·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Dass S VinayByoung S Kwon
Sep 28, 2005·Cancer Immunology, Immunotherapy : CII·Koji Tamada, Lieping Chen
May 14, 2005·Cancer Immunology, Immunotherapy : CII·Adam T C CheukBarbara-ann Guinn
Jul 28, 2007·Cancer Immunology, Immunotherapy : CII·Despina RudolfStefan Stevanović
Mar 5, 2009·Cancer Immunology, Immunotherapy : CII·Claudia Gravekamp
Jul 8, 2010·Cancer Immunology, Immunotherapy : CII·Juan DubrotIgnacio Melero
Oct 5, 2011·Cancer Immunology, Immunotherapy : CII·Shuzhen WangYijun Chen
Sep 5, 2006·Springer Seminars in Immunopathology·Juergen Foell, Robert S Mittler
Aug 9, 2013·Molecules and Cells·Chang Ho YunByung Ju Lee
Jan 29, 2011·Cancer Metastasis Reviews·Roch HouotRonald Levy
Dec 31, 2003·Current Treatment Options in Oncology·Scott E Strome, Lieping Chen
Aug 11, 2005·Current Oncology Reports·Christian H PoehleinBernard A Fox
Jun 21, 2012·Pathology Oncology Research : POR·Md ZeyaullahArif Ali
Oct 17, 2012·Pathology Oncology Research : POR·Kuang YoulinChen Zhiyuan
Oct 5, 2013·Immunobiology·Julia María Martínez GómezSylvie Alonso
Nov 12, 2003·The Journal of Allergy and Clinical Immunology·Tanuja Chitnis, Samia J Khoury
Apr 17, 2004·Journal of Immunological Methods·Ji Hee SonJeong Woo Park
Nov 8, 2003·Trends in Molecular Medicine·Yonglian SunYang-Xin Fu
Mar 5, 2013·Veterinary Immunology and Immunopathology·Xinxin ZhaoXun Suo
Apr 30, 2003·Cellular Immunology·Hiroshi TanakaSuyu Shu
Oct 7, 2003·Cellular Immunology·Hyeon-Woo LeeByoung S Kwon
Jun 8, 2001·Mechanisms of Ageing and Development·C Gravekamp
Sep 21, 2000·Immunology Letters·F OssendorpC J Melief
Aug 1, 2000·Immunology Today·M J Glennie, P W Johnson
Sep 28, 2000·Current Opinion in Immunology·A A HurwitzA van Elsas
Mar 20, 2001·Critical Reviews in Oncology/hematology·H H van Ojik, T Valerius
Jul 6, 2002·Critical Reviews in Oncology/hematology·Rong-Fu WangHan Ying
May 29, 2002·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·Yoshinori SekoRyozo Nagai
Oct 13, 2000·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·K Tamada, L Chen
Jun 6, 2003·Cytokine & Growth Factor Reviews·Michael Croft
May 4, 2010·Journal of the American Chemical Society·Chenghong LeiKarl Erik Hellstrom
Jan 9, 2013·Immunology and Cell Biology·Marie-Clare St RoseAdam J Adler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.